BioCentury
ARTICLE | Financial News

Supernus proposes $75M note deal

April 25, 2013 12:01 AM UTC

Supernus Pharmaceuticals Inc. (NASDAQ:SUPN) said late Wednesday it plans to raise $75 million through the sale to institutional investors of convertible senior secured notes due 2019. Earlier this yea...